The study of cardiomyocytes mitochondrial dysfunction in hyperhomocysteinemia and nitric oxyde deficiency

Cover Page


Cite item

Full Text

Abstract

Aim. To study the influence of nitric oxide metabolism disturbance on the development of mitochondrial dysfunction in case of hyperhomocysteinemia.

Methods. The research was conducted on 32 Wistar male rats. Hyperhomocysteinemia was simulated by intragastric injection of methionine suspension prepared using starch and Tween-80 with addition of this amino acid into the drinking water. The nitric oxide deficiency was induced by intraperitoneal injection of L-Nω-nitroarginine methyl ester (L-NAME) solution.

Results. Hyperhomocysteinemia is accompanied by dysfunction of cardiac cells mitochondria, manifesting in growth of cytoplasmic lactate level and development of oxidative stress with increased mitochondrial proteins carbonylation. Oxidative stress is largely compensated by the activation of the antioxidant defense system (including superoxide dismutase), as evidenced by a slight decrease of succinate dehydrogenase and H+-ATPase activity, the absence of statistically significant changes of cytoplasmic lactate dehydrogenase activity. Tween-80 showed antioxidant properties, reducing the content of protein carbonyl derivatives and superoxide dismutase activity. Nitric oxide deficiency caused by the L-NAME injection was accompanied by an inhibition of aerobic oxidation processes in cardiomyocytes mitochondria, which was proved by a significant decrease in succinate dehydrogenase activity as well as slight reduction of lactate dehydrogenase activity and lactate accumulation in the cytoplasm, and an oxidative phosphorylation reduction which manifested with a decrease of H+-ATPase activity. One reason for these changes is increased carbonylation of proteins due to high production of reactive oxygen species, which is not sufficiently compensated by increased activity of superoxide dismutase.

Conclusion. Since hyperhomocysteinemia is associated with reduced concentrations of nitric oxide metabolites in cardiomyocytes mitochondria, and changes in these organelles after the administering of methionine have some similarities with those after injection of L-NAME, it can be argued that nitric oxide deficiency plays an important role in the pathogenesis of mitochondrial dysfunction of cardiomyocytes in case of hyperhomocysteinemia.

About the authors

D V Medvedev

Ryazan State Medical University, Ryazan, Russia

Author for correspondence.
Email: meddmit@mail.ru

V I Zvyagina

Ryazan State Medical University, Ryazan, Russia

Email: meddmit@mail.ru

References

  1. Биоэнергетика клетки. Химия патологических процессов / Под ред. В.Ю. Сереброва, Г.А. Сухановой. - Томск: Сиб. гос. мед. ун-т, 2008. - С. 79-82.
  2. Глущенко С.В. Гипергомоцистеинемия как предиктор развития и прогрессирования неалкогольной жировой болезни печени // Пробл. безперервноï мед. освiти та науки. - 2014. - №2. - С. 89-92.
  3. Дубинина Е.Е. Продукты метаболизма кислорода в функциональной активности клеток (жизнь и смерть, созидание и разрушение). Физиологические и клинико-биохимические аспекты. - СПб.: Мед. пресса, 2006. - С. 276-282.
  4. Костюк В.А., Потапович А.И., Ковалёва Ж.В. Простой и чувствительный метод определения активности супероксиддисмутазы, основанный на реакции окисления кверцетина // Вопр. мед. хим. - 1990. - №2. - С. 88-91.
  5. Медведев Д.В., Звягина В.И., Фомина М.А. Способ моделирования тяжёлой формы гипергомоцистеинемии у крыс // Рос. мед.-биол. вестн. им. И.П. Павлова. - 2014. - №4. - С. 42-46.
  6. Метельская В.А., Гуманова Н.Г. Скрининг-метод определения уровня метаболитов оксида азота в сыворотке // Клин. лаб. диагност. - 2005. - №6. - С. 15-18.
  7. Методы биохимических исследований (липидный и энергетический обмен) / Под ред. М.И. Прохоровой. - Л.: Изд-во Ленинградского ун-та, 1982. - 327 с.
  8. Оганов Р.Г. Сердечно-сосудистые заболевания в начале XXI века: медицинские, социальные, демографические аспекты и пути профилактики // Медицина труда, восстановительная и профилактическая медицина. - 2010. - Т. 11. - С. 257-264.
  9. Плоцкий А.Р. Роль гомоцистеина в генезе врождённых пороков развития плода // Репрод. здоровье в Беларуси. - 2009. - №5 (05). - С. 58-65.
  10. Фомина М.А., Абаленихина Ю.В., Фомина Н.В., Терентьев А.А. Способ комплексной оценки содержания продуктов окислительной модификации белков в тканях и биологических жидкостях. Патент №2524667 РФ, МПК 11, G01N33/52. Бюлл. №21 от 27.07.2014.
  11. Arun K., Lijo J., Shuvadeep M. et al. Converging evidence of mitochondrial dysfunction in a yeast model of homocysteine metabolism imbalance // J. Biol. Chem. - 2011. - Vol. 286, N 24. - P. 21 779-21 795.
  12. Herrmann W., Obeid R. Homocysteine: a biomarker in neurodegenerative diseases // Clin. Chem. Lab. Med. (CCLM). - 2011. - Vol. 49, iss. 3. - P. 435-441. http://dx.doi.org/10.1515/cclm.2011.084
  13. Martinez-Ruiz A., Cadenas S., Lamas S. Nitric oxide signaling: classical, less classical, and nonclassical mechanisms // Free Rad. Biol. Med. - 2011. - Vol. 51, iss. 1. - P. 17-29. http://dx.doi.org/10.1016/j.freeradbiomed.2011.04.010
  14. McCully K.S. Hyperhomocysteinemia and arteriosclerosis: historical perspectives // Clin. Chem. Lab. Med. (CCLM). - 2005. - Vol. 43, iss. 10. - P. 980-986. http://dx.doi.org/10.1515/CCLM.2005.172
  15. Pérez-Rosés R., Risco E., Vila R. et al. Antioxidant activity of Tween-20 and Tween-80 evaluated through different in-vitro tests // J. Pharmac. Pharmacol. - 2015. - Vol. 67, N 5. - P. 666-672. http://dx.doi.org/10.1111/jphp.12369
  16. Stühlinger M.C., Tsao P.S., Jeng-Horng H. et al. Homocysteine impairs the nitric oxide synthase pathway. Role of asymmetric dimethylarginine // Circulation. - 2001. - Vol. 104. - P. 2569-2575. http://dx.doi.org/10.1161/hc4601.098514
  17. Wink D.A., Miranda K.M., Espey M.G. et al. Mechanisms of the antioxidant effects of nitric oxide // Antioxidants Redox Signaling. - 2001. - Vol. 3, N 2. - P. 203-213. http://dx.doi.org/10.1089/152308601300185179
  18. Zun Y.W., Hakanson R. Role of nitric oxide (NO) in ocular inflammation // Brit. J. Pharmacol. - 1995. - Vol. 116. - P. 244-245.

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2015 Medvedev D.V., Zvyagina V.I.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies